Dolby Laboratories reported total revenue of $357 million for Q1 2025, compared to $316 million in Q1 2024. GAAP net income was $68 million, or $0.70 per diluted share, compared to $67 million, or $0.69 per diluted share, for the same quarter last year. Non-GAAP net income was $111 million, or $1.14 per diluted share, compared to $99 million, or $1.01 per diluted share, in Q1 2024.
Total revenue reached $357 million, up from $316 million in the first quarter of fiscal 2024.
GAAP net income was $68 million, or $0.70 per diluted share.
Non-GAAP net income amounted to $111 million, or $1.14 per diluted share.
Dolby repurchased approximately 186,000 shares of its common stock for approximately $15 million.
Dolby provided estimates for its second quarter of fiscal 2025 and full year fiscal 2025.
Visualization of income flow from segment revenue to net income